U.K. Becomes First Country to Approve a CRISPR Disease Treatment

A newly approved CRISPR therapy could transform the treatment of sickle cell disease and beta-thalassemia—but the technology is expensive
U.K. Becomes First Country to Approve a CRISPR Disease Treatment

A newly approved CRISPR therapy could transform the treatment of sickle cell disease and beta-thalassemia—but the technology is expensive
No replies yet.